A predictive signature for therapy assignment and risk assessment in prostate cancer

Désirée Bonci, Ruggero De Maria

Research output: Contribution to journalArticlepeer-review

Abstract

Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

Original languageEnglish
Pages (from-to)920-923
Number of pages4
JournalOncoscience
Volume2
Issue number11
DOIs
Publication statusPublished - 2015

Keywords

  • Genes
  • miRNA
  • Non-coding RNA
  • Prostrate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'A predictive signature for therapy assignment and risk assessment in prostate cancer'. Together they form a unique fingerprint.

Cite this